The total annual funding for biomedical research in the U.S. has slowed and may have even shrunk, according to an analysis completed by researchers at the University of Rochester Medical Center.
The study showed that when figures were adjusted for inflation annual research funding grew 3.4 percent from 2003 to 2007 and decreased in 2008.
The era of rapid expansion in biomedical research funding that began in the 1990’s has ended. Looking back at this period, one of the striking observations is that while research funding increased, the number of novel treatments entering the market remained steady. If research funding levels are to return to a phase of growth, we should examine funding priorities, particularly in health services research, and barriers to the development of new therapies.